ZAS Onco Team Charts the Course with “Leap Into 2025”
The ZAS Onco Team commenced 2025 on a high note with their annual strategic and planning meeting titled “Leap Into […]
The ZAS Onco Team commenced 2025 on a high note with their annual strategic and planning meeting titled “Leap Into […]
The ZAS Critical Care Team commenced 2025 on a high note with their annual strategic and planning meeting titled “Leap
Our Baby Care team recently hosted an engaging and insightful Round Table discussion with leading pediatricians, focusing on the prevention
As we enter 2025, we are filled with renewed energy and a shared vision for a brighter future. At ZAS,
ZAS Corporation Ltd. is proud to announce the signing of a Memorandum of Understanding (MOU) with The Ibn Sina Trust,
ZAS Corporation Headquarters team wrapped up 2024 with an unforgettable recreation tour to the picturesque beaches of Kuakata. Surrounded by
ZAS Corporation Ltd. is delighted to announce the signing of a Memorandum of Understanding (MOU) with LABAID Diagnostics and LABAID
ZAS Corporation proudly launched Uro-Vaxom, an advanced immunotherapeutic solution by OM Pharma, Switzerland, for preventing recurrent urinary tract infections (UTIs).
In collaboration with the Nephrology Department at the National Institute of Kidney Diseases & Urology (NIKDU), ZAS Corporation Ltd. hosted
ZAS Corporation proudly participated in the prestigious MOSB Congress 2024, reaffirming its dedication to advancing oncology care in Bangladesh. The